分开在一起:走向生物固定装置地位的核心
Kelsey Gipe1,2,3
1Sutter Health Program in Medicine & Human Values, California, USA.
The Journal of medicine and philosophy
|January 11, 2026
概括
医疗植入物,如心室辅助器件 (VADs),正在被探索.
科学领域:
- 医学伦理学医学伦理学
- 生物医学工程 生物医学工程
- 临床哲学 临床哲学
背景情况:
- 医疗植入物和疗法引发了复杂的伦理问题.
- 提供者对像心室辅助器件 (VADs) 这样的禁用设备感到不舒服,这表明他们具有独特的道德地位.
- 之前的研究发现了节律起器是生物固件,这促使进一步研究其他设备.
研究的目的:
- 定义和建立"生物固定装置"地位的标准.
- 为了确定VAD是否符合生物固定剂的条件.
- 探索关闭生物固定装置的道德影响.
主要方法:
- 概念分析,以制定生物固定装置地位的标准.
- 这些标准应用于VAD和其他心肺疗法.
- 对VAD禁用周围的提供者不适的案例研究分析.
主要成果:
- 有人认为心室辅助装置 (VAD) 是生物固定装置.
- 关闭VAD在道德上类似于主动安乐死,而不是标准的生命支持退出.
- 制定了生物固定剂状态的标准,并应用于心肺疗法.
结论:
- VADs具有与本地身体部位相似的道德特征.
- 生物固定剂的概念为理解先进医疗技术的伦理困境提供了一个新的框架.
- 需要进一步的研究才能充分理解生物固定剂在临床实践中的道德意义.
更多相关视频
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
520
06:15A Hydrogel Construct and Fibrin-based Glue Approach to Deliver Therapeutics in a Murine Myocardial Infarction Model.
Published on: June 14, 2015
9.2K
相关概念视频
Heart Failure IV: Classification and Diagnostic Evaluation
310
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
310
Disturbances in Heart Rhythm
2.5K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
2.5K
Pathophysiology of Heart Failure
2.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.8K
Heart Failure Drugs: β-Blockers
755
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
755
Pulse rhythm
1.3K
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
1.3K
Heart Failure Drugs: Inotropic Agents
1.2K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.2K
